News | April 28, 2014
Cardiosonic Ltd. announced CE marking of its TIVUS (therapeutic intravascular ultrasound) ablative catheter device.
Feature | July 30, 2013 | Dave Fornell
One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat...
News | April 24, 2013
Cardiosonic Inc. announced the completion of the first phase of patient enrollment in its first-in-man (FIM) TIVUS I...
News | December 27, 2012
December 27, 2012 — Cardiosonic Inc., a private developer of technology in the field of renal denervation for the...